GR74594B - - Google Patents

Info

Publication number: GR74594B
Authority: GR; Greece
Prior art keywords: hav; hepatitis; virus; produced; hollow fiber
Prior art date: 1980-07-23

Application number

GR65567A

Other languages

English (en)

Inventor

Henry Z Markus

William J Mcaleer

Original Assignee

Merck & Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-07-23

Filing date

1981-07-20

Publication date

1984-06-29

1981-07-20 Application filed by Merck & Co Inc filed Critical Merck & Co Inc

1984-06-29 Publication of GR74594B publication Critical patent/GR74594B/el

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32451—Methods of production or purification of viral material
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Mycology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

GR65567A 1980-07-23 1981-07-20 GR74594B (el)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/171,621 US4301249A (en)	1980-07-23	1980-07-23	High titer production of hepatitis A virus

Publications (1)

Publication Number	Publication Date
GR74594B true GR74594B (el)	1984-06-29

Family

ID=22624494

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR65567A GR74594B (el)	1980-07-23	1981-07-20

Country Status (11)

Country	Link
US (1)	US4301249A (el)
EP (1)	EP0044793B1 (el)
JP (1)	JPS5753410A (el)
AT (1)	ATE20250T1 (el)
CA (1)	CA1187413A (el)
DE (1)	DE3174765D1 (el)
DK (1)	DK326781A (el)
ES (1)	ES8205016A1 (el)
GR (1)	GR74594B (el)
IE (1)	IE51454B1 (el)
PT (1)	PT73371B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4783407A (en) *	1985-09-30	1988-11-08	Merck & Co., Inc.	Growth of hepatitus A virus in vero cells
DE3633550A1 (de) *	1986-10-02	1988-04-14	Behringwerke Ag	Vaccine gegen hepatitis a
US5268292A (en) *	1988-06-27	1993-12-07	Robertson Betty H	Reproducible generation of high yields of hepatitis A virus by cell culture
EP0564539A4 (en) *	1990-12-13	1996-03-06	Us Commerce	Sustained and continuous production of high titers of recombinant viral vectors and transduced target cells for use in gene therapy
US5506129A (en) *	1991-05-24	1996-04-09	Evans Medical Limited	Virus production
DZ1706A1 (fr) *	1992-08-07	2002-02-17	Merck & Co Inc	Vaccin contre le virus de l'hepatite a.
US5354692A (en) *	1992-09-08	1994-10-11	Pacific Biotech, Inc.	Analyte detection device including a hydrophobic barrier for improved fluid flow
HRP950097A2 (en) *	1994-03-08	1997-06-30	Merck & Co Inc	Hepatitis a virus culture process
US5498537A (en) *	1994-03-09	1996-03-12	Cellco, Inc.	Serum-free production of packaged viral vector
US20020182730A1 (en) *	1995-07-26	2002-12-05	Micheal L. Gruenberg	Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
FR2821947B1 (fr) *	2001-03-12	2003-05-16	Canon Kk	Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) *	2001-09-19	2003-07-17	Gruenberg Micheal L.	Th1 cell adoptive immunotherapy
US20030134341A1 (en) *	2001-09-19	2003-07-17	Medcell Biologics, Llc.	Th1 cell adoptive immunotherapy
US20030175272A1 (en) *	2002-03-07	2003-09-18	Medcell Biologics, Inc.	Re-activated T-cells for adoptive immunotherapy
CA2480121C (en) *	2002-03-27	2012-02-28	Immunex Corporation	Methods for increasing polypeptide production
EP2067856A4 (en) *	2006-09-26	2012-11-07	Toyo Boseki	METHOD FOR PROLIFERATING A HEPATITIS VIRUS, HOLLOW FIBER FOR CULTURING HEPATITIS VIRUS-INFECTED CELLS AND USE THEREOF
KR101581228B1 (ko) *	2007-05-04	2015-12-30	백스터 인터내셔널 인코포레이티드	바이러스의 증식을 위한 ２-단계 온도 프로파일
JP5692688B2 (ja) *	2008-06-26	2015-04-01	東洋紡株式会社	感染性ｃ型肝炎ウイルス粒子の製造方法、およびその利用
EP2686423A4 (en)	2011-03-14	2015-01-28	Nat Res Council Canada	METHOD FOR PRODUCING VIRUSES IN CELLS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3615024A (en) *	1968-08-26	1971-10-26	Amicon Corp	High flow membrane
US3821087A (en) *	1972-05-18	1974-06-28	Dedrick R	Cell culture on semi-permeable tubular membranes
US3883393A (en) *	1972-05-18	1975-05-13	Us Health Education & Welfare	Cell culture on semi-permeable tubular membranes
CH593339A5 (el) *	1973-07-02	1977-11-30	Monsanto Co
US4087327A (en) *	1976-04-12	1978-05-02	Monsanto Company	Mammalion cell culture process
FR2398504A1 (fr)	1977-07-29	1979-02-23	Tours Inst Virologie	Culture de virus de l'hepatite a, in vitro. application a la production d'un antigene reactif, d'immunserums specifiques et de vaccins contre l'hepatite a
US4164566A (en) *	1978-08-17	1979-08-14	Merck & Co., Inc.	Hepatitis a virus cell culture in vitro
US4301250A (en) *	1979-11-02	1981-11-17	Merck & Co., Inc.	Method of producing hepatitis B surface antigen

1980
- 1980-07-23 US US06/171,621 patent/US4301249A/en not_active Expired - Lifetime
1981
- 1981-07-14 CA CA000381716A patent/CA1187413A/en not_active Expired
- 1981-07-15 PT PT73371A patent/PT73371B/pt unknown
- 1981-07-20 GR GR65567A patent/GR74594B/el unknown
- 1981-07-22 AT AT81401172T patent/ATE20250T1/de not_active IP Right Cessation
- 1981-07-22 DK DK326781A patent/DK326781A/da not_active Application Discontinuation
- 1981-07-22 EP EP81401172A patent/EP0044793B1/en not_active Expired
- 1981-07-22 DE DE8181401172T patent/DE3174765D1/de not_active Expired
- 1981-07-22 ES ES504199A patent/ES8205016A1/es not_active Expired
- 1981-07-22 IE IE1655/81A patent/IE51454B1/en not_active IP Right Cessation
- 1981-07-23 JP JP56114522A patent/JPS5753410A/ja active Pending

Also Published As

Publication number	Publication date
EP0044793B1 (en)	1986-06-04
ATE20250T1 (de)	1986-06-15
EP0044793A3 (en)	1983-01-05
EP0044793A2 (en)	1982-01-27
US4301249A (en)	1981-11-17
JPS5753410A (en)	1982-03-30
PT73371B (en)	1983-06-15
ES504199A0 (es)	1982-05-16
PT73371A (en)	1981-08-01
IE811655L (en)	1982-01-23
CA1187413A (en)	1985-05-21
ES8205016A1 (es)	1982-05-16
DE3174765D1 (en)	1986-07-10
DK326781A (da)	1982-01-24
IE51454B1 (en)	1986-12-24

Publication	Publication Date	Title
IE811655L (en)	1982-01-23	Hepatitis a virus
FI861882A (fi)	1986-11-08	Underlag foer odling utan mull.
IE882407L (en)	1989-02-06	Purifying hepatitis a virus
GB8704032D0 (en)	1987-03-25	Light emitter bias stabilization
GR880100346A (el)	1989-02-23	Μεθοδος βαφης κερατινικων ινων με βασεις οξειδωσεως συνδιαζομενες με ιωδιουχο αλας, βαφικη συνθεση & διαταξη που χρησιμοποιειται
DK0414475T3 (da)	1998-02-09	Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
GR74755B (el)	1984-07-11
DE3789487D1 (de)	1994-05-05	Vorrichtung zur Erzeugung von Elektronenstrahlen.
DK372780A (da)	1981-03-05	Fremgangsmaade til propagering af humant hepatitis a virus
DE3780666D1 (de)	1992-09-03	Einrichtung zur erzeugung von vibrationen.
FI853618A0 (fi)	1985-09-20	Stabilisering av enzymer anvaendbara foer produktion av glukoson och i andra enzymatiska processer.
DE68924155D1 (de)	1995-10-12	Verfahren zur herstellung von natürlichem hiv-glykoprotein 160.
IT7850724A0 (it)	1978-08-11	Fibre di carbonio acriliche e procedimento per produrle
ES2028968T3 (es)	1992-07-16	Sistema de gobierno de la produccion.
DE68913059D1 (de)	1994-03-24	Vorrichtung zur Befestigung von Glasfasern an photoelektrischen Schaltern.
DE69013285D1 (de)	1994-11-17	Manipulierbarer Vakuum-Extraktor als Kindergeburtshilfe.
ES8502092A1 (es)	1984-12-16	Un procedimiento de resolucion de trans-d1-1-n-propil-6-oxodecahidroquinolina en sus isomeros opticos
DE68908843D1 (de)	1993-10-07	Verfahren zur Herstellung von 4,6-Dimethyl-7-hydroxynonan-3-on.
IT8667710A0 (it)	1986-09-18	Serra di coltura
EP0248425A3 (en)	1989-01-25	Emitter with a transistorized push-pull output stage
JPS5439145A (en)	1979-03-26	Light source device
DE68926467D1 (de)	1996-06-20	Elektronenemitter
SU1692146A1 (ru)	2000-03-20	Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o
DK0403015T3 (da)	1995-05-15	Fremgangsmåde til dyrkning af celler
GB8622883D0 (en)	1986-10-29	Expression of hepatitis b viral antigens